Editorial: Winners of the 2010 Eberhard F. Mammen award for most popular article during 20082009

Seminars in Thrombosis and Hemostasis

Volumn 36, Issue 7, 2010, Pages 685-692

  Favaloro, Emmanuel J ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR; BLOOD CLOTTING INHIBITOR; HEPARIN; PROTHROMBIN A INHIBITOR; UNCLASSIFIED DRUG;

AWARDS AND PRIZES; CARDIOVASCULAR DISEASE; EDITORIAL; HEMOSTASIS; MEDICAL LITERATURE; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTOPENIA; THROMBOSIS; HISTORY; HUMAN;

AWARDS AND PRIZES; HISTORY, 21ST CENTURY; HUMANS; THROMBOSIS;

EID: 78049309057     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1265830     Document Type: Editorial

References (57)

1. Favaloro E J. Editorial. Welcome to a special issue of Seminars in Thrombosis and Hemostasisthe closing issue for 2008. Semin Thromb Hemost 2008 34 693-696
2. Favaloro E J. A tribute to Eberhard F. Mammen, M.D. (19302008). Semin Thromb Hemost 2008 34 (8) 703-707
3. Favaloro E J. Editorial. Welcome to the first issue of Seminars in Thrombosis and Hemostasis for 2009. Semin Thromb Hemost 2009 35 1-2
4. Favaloro E J. Editorial. Winners of the Inaugural Eberhard F. Mammen Award for Most Popular Article. Semin Thromb Hemost 2009 35 587-590
5. Favaloro E J. Editorial. 2009 Eberhard F. Mammen Young Investigator Award Winners. Semin Thromb Hemost 2010 36 (6) 469-470
6. Harenberg J, Wehling M. Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa. Semin Thromb Hemost 2008 34 (1) 39-57
7. Prechel M, Walenga J M. The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update. Semin Thromb Hemost 2008 34 (1) 86-96
8. Fareed J, Hoppensteadt D A., Fareed D et al. Survival of heparins, oral anticoagulants, and aspirin after the year 2010. Semin Thromb Hemost 2008 34 (1) 58-73
9. Asherson R A., Cervera R, Merrill J T., Erkan D. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment. Semin Thromb Hemost 2008 34 (3) 256-266
10. Jurk K, Kehrel B E. Platelets: physiology and biochemistry. Semin Thromb Hemost 2005 31 (4) 381-392
11. Wong R C., Favaloro E J. Clinical features, diagnosis, and management of the antiphospholipid syndrome. Semin Thromb Hemost 2008 34 (3) 295-304
12. Enjeti A K., Lincz L F., Seldon M. Detection and measurement of microparticles: an evolving research tool for vascular biology. Semin Thromb Hemost 2007 33 (8) 771-779
13. Tincani A, Bazzani C, Zingarelli S, Lojacono A. Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment. Semin Thromb Hemost 2008 34 (3) 267-273
14. Viiala N O., Larsen S R., Rasko J E. Gene therapy for hemophilia: clinical trials and technical tribulations. Semin Thromb Hemost 2009 35 (1) 81-92
15. Pierangeli S S., Chen P P., Raschi E et al. Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms. Semin Thromb Hemost 2008 34 (3) 236-250
16. Tripodi A, van den Besselaar A. Laboratory monitoring of anticoagulation: where do we stand? Semin Thromb Hemost 2009 35 (1) 34-41
17. Sobieraj-Teague M, O'Donnell M, Eikelboom J. New anticoagulants for atrial fibrillation. Semin Thromb Hemost 2009 35 (5) 515-524
18. Lippi G, Favaloro E J., Franchini M, Guidi G C. Milestones and perspectives in coagulation and hemostasis. Semin Thromb Hemost 2009 35 (1) 9-22
19. Tiu R V., Mountantonakis S E., Dunbar A J., Schreiber M Jr.J. Tumor lysis syndrome. Semin Thromb Hemost 2007 33 (4) 397-407
20. Watson H G., Greaves M. Can we predict bleeding? Semin Thromb Hemost 2008 34 (1) 97-103
21. Hunt B J. Pediatric antiphospholipid antibodies and antiphospholipid syndrome. Semin Thromb Hemost 2008 34 (3) 274-281
22. Laux V, Perzborn E, Kubitza D, Misselwitz F. Preclinical and clinical characteristics of rivaroxaban: a novel, oral, direct factor Xa inhibitor. Semin Thromb Hemost 2007 33 (5) 515-523
23. Blum W, Porcu P. Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome. Semin Thromb Hemost 2007 33 (4) 350-354
24. Boekholdt S M., Kramer M H. Arterial thrombosis and the role of thrombophilia. Semin Thromb Hemost 2007 33 (6) 588-596
25. Franchini M, Franchi M, Bergamini V, Salvagno G L., Montagnana M, Lippi G. A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage. Semin Thromb Hemost 2008 34 (1) 104-112
26. Levi M, Löwenberg E C. Thrombocytopenia in critically ill patients. Semin Thromb Hemost 2008 34 (5) 417-424
27. Cohn D M., Roshani S, Middeldorp S. Thrombophilia and venous thromboembolism: implications for testing. Semin Thromb Hemost 2007 33 (6) 573-581
28. Wada H, Usui M, Sakuragawa N. Hemostatic abnormalities and liver diseases. Semin Thromb Hemost 2008 34 (8) 772-778
29. Jeske W P., Walenga J M., Hoppensteadt D A. et al. Differentiating low-molecular-weight heparins based on chemical, biological, and pharmacologic properties: implications for the development of generic versions of low-molecular-weight heparins. Semin Thromb Hemost 2008 34 (1) 74-85
30. Ho V T., Linden E, Revta C, Richardson P G. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: review and update on the use of defibrotide. Semin Thromb Hemost 2007 33 (4) 373-388
31. Galli M. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome. Semin Thromb Hemost 2008 34 (4) 329-334
32. Favaloro E J. Clinical utility of the PFA-100. Semin Thromb Hemost 2008 34 (8) 709-733
33. Bernardi E, Pesavento R, Prandoni P. Upper extremity deep venous thrombosis. Semin Thromb Hemost 2006 32 (7) 729-736
34. Selleng K, Selleng S, Greinacher A. Heparin-induced thrombocytopenia in intensive care patients. Semin Thromb Hemost 2008 34 (5) 425-438
35. Harenberg J. Development of new anticoagulants: present and future. Semin Thromb Hemost 2008 34 (8) 779-793
36. Mariani G, Bernardi F. Factor VII deficiency. Semin Thromb Hemost 2009 35 (4) 400-406
37. Gisondi P, Girolomoni G. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors. Semin Thromb Hemost 2009 35 (3) 313-324
38. Esmon C T. Inflammation and the activated protein C anticoagulant pathway. Semin Thromb Hemost 2006 32 (Suppl 1) 49-60
39. Schaffner F, Ruf W. Tissue factor and protease-activated receptor signaling in cancer. Semin Thromb Hemost 2008 34 (2) 147-153
40. Roberts H R., Hoffman M, Monroe D M. A cell-based model of thrombin generation. Semin Thromb Hemost 2006 32 (Suppl 1) 32-38
41. Harris E N., Pierangeli S S. Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name? Semin Thromb Hemost 2008 34 (3) 219-226
42. Wong R C., Favaloro E J. Antiphospholipid antibodies and the antiphospholipid syndrome. I: pathogenesis, clinical features, diagnosis, and management. Preface. Semin Thromb Hemost 2008 34 (3) 213-218
43. Douma R A., Kamphuisen P W. Thrombolysis for pulmonary embolism and venous thrombosis: is it worthwhile? Semin Thromb Hemost 2007 33 (8) 821-828
44. Lippi G, Franchini M, Montagnana M, Guidi G C. Coagulation testing in pediatric patients: the young are not just miniature adults. Semin Thromb Hemost 2007 33 (8) 816-820
45. McGlasson D L., Fritsma G A. Whole blood platelet aggregometry and platelet function testing. Semin Thromb Hemost 2009 35 (2) 168-180
46. Zakarija A, Bennett C. Drug-induced thrombotic microangiopathy. Semin Thromb Hemost 2005 31 (6) 681-690
47. Espinosa G, Bucciarelli S, Asherson R A., Cervera R. Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors. Semin Thromb Hemost 2008 34 (3) 290-294
48. Miesbach W. Neurologic symptoms as a feature of the antiphospholipid syndrome. Semin Thromb Hemost 2008 34 (3) 286-289
49. Girolami B, Girolami A. Heparin-induced thrombocytopenia: a review. Semin Thromb Hemost 2006 32 (8) 803-809
50. Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Hemost 2009 35 (2) 189-203
51. Favaloro E J., Wong R C. Laboratory testing and identification of antiphospholipid antibodies and the antiphospholipid syndrome: a potpourri of problems, a compilation of possible solutions. Semin Thromb Hemost 2008 34 (4) 389-410
52. Savi P, Herbert J M. Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. Semin Thromb Hemost 2005 31 (2) 174-183
53. Dempfle C E., Borggrefe M. Point of care coagulation tests in critically ill patients. Semin Thromb Hemost 2008 34 (5) 445-450
54. Kenet G, Strauss T, Kaplinsky C, Paret G. Hemostasis and thrombosis in critically ill children. Semin Thromb Hemost 2008 34 (5) 451-458
55. Harrison P, Mumford A. Screening tests of platelet function: update on their appropriate uses for diagnostic testing. Semin Thromb Hemost 2009 35 (2) 150-157
56. Favaloro E J. Measuring the quality of journals and journal articles: the impact factor tells but a portion of the story. Semin Thromb Hemost 2008 34 (1) 7-25
57. Favaloro E J., Wong R C. Dedication: Professor Ronald A. Asherson, M.D. (Hon), F.R.C.P., M.D., F.A.C.P., F.C.P., F.A.C.R., Dip. O&G (Hon) [19342008]. Semin Thromb Hemost 2008 34 (3) 211